Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POM121 transmembrane nucleoporin like 13, pseudogene (POM121L13P) is a human gene annotated as a pseudogene, meaning it is a non-functional copy that resembles the POM121 gene but does not encode a functional protein due to disrupting mutations or loss of coding potential[1][4][6]. Like other pseudogenes, it may have regulatory functions at the transcriptional or epigenetic level, potentially impacting the expression of related genes, but it is not considered a druggable therapeutic target nor a classical receptor, enzyme, transporter, or other molecular target family member[2]. The only disease association currently listed is with gastric cardia adenocarcinoma, but this is likely based on the gene locus rather than direct functional involvement[4]. Key points: - POM121L13P is not a functional protein or receptor[1][6]. - It is classified as a pseudogene and is not a therapeutic target[1][2][4][6]. - It does not have known protein interactions, mechanisms of drug action, biomarker applications, or recognized safety concerns related to therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POM121 transmembrane nucleoporin like 13, pseudogene (POM121L13P).